CRDL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cardiol Therapeutics Inc (CRDL) is not a strong buy at this time for a beginner investor with a long-term strategy. The technical indicators are bearish, financial performance is weak, and there are no significant positive catalysts or trading signals to justify immediate action.
The MACD is negative and expanding downward (-0.00272), RSI is neutral (40.673), and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.988 and resistance at 1.022. Overall, the technical indicators suggest a bearish trend.
NULL. There are no recent news updates, insider activity, or hedge fund interest to act as positive catalysts. The stock has a 60% chance of gaining 6.8% in the next month, but this is not a strong indicator for long-term investment.
Technical indicators are bearish, and there is no recent congress trading data or influential figure activity to provide confidence.
In Q3 2025, revenue remained at 0 with no growth, net income dropped to -9,964,281 (-21.72% YoY), and EPS declined to -0.12 (-33.33% YoY). Gross margin was 0, indicating no profitability.
No analyst rating or price target data is available for CRDL. Wall Street sentiment is neutral, with no significant trends in hedge fund or insider trading activity.
